Stocks of Agilon Health Inc (NYSE:AGL) traded higher last session on Wall Street, down -13.43% to $1.87.
AGL stock price is now -41.28% away from the 50-day moving average and -63.80% away from the 200-day moving average. The market capitalization of the company currently stands at $770.47M.
, while ‘Citigroup’ rates the stock as ‘Sell’
In other news, Sell Steven, CEO & President bought 20,000 shares of the company’s stock on Sep 12 ’24. The stock was bought for $67,188 at an average price of $3.36. Upon completion of the transaction, the CEO & President now directly owns 67,590 shares in the company, valued at $0.13 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 29 ’23, Director Schwaneke Jeffrey A. bought 22,300 shares of the business’s stock. A total of $250,206 was incurred on buying the stock at an average price of $11.22. This leaves the insider owning 31,931 shares of the company worth $59710.97. A total of 26.41% of the company’s stock is owned by insiders.
During the past 12 months, Agilon Health Inc has had a low of $1.80 and a high of $13.76. As of last week, the company has a debt-to-equity ratio of 0.08, a current ratio of 1.29, and a quick ratio of 1.29. The fifty day moving average price for AGL is $3.224 and a two-hundred day moving average price translates $5.18595 for the stock.
The latest earnings results from Agilon Health Inc (NYSE: AGL) was released for 2024-09-30. The net profit margin was -6.01% and return on equity was -42.98% for AGL. The company reported revenue of $1.45 billion for the quarter, compared to $1.14 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 27.63 percent.
